Impact of a diagnostic therapeutic educational pathway program for asthma management in preschool children.

Before-after evaluation Children Diagnostic-therapeutic-educational pathway GINA guidelines Infant Patient and family education Preschool asthma Wheezing

Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
10 Mar 2021
Historique:
received: 10 07 2020
accepted: 16 02 2021
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 30 10 2021
Statut: epublish

Résumé

Preschool children with clinically-diagnosed asthma have a higher rate of emergency department visits and consume more resources for management than older children. However, no clinical trials have yet been performed measuring the impact of a combined diagnostic, therapeutic and educational pathway regimen for evaluation of wheezing control in children aged less than 6 years. The purpose of the present study was to assess the impact of a pediatric program developed in Italy, the Diagnostic Therapeutic Educational Pathway (DTEP), for asthma management in children less than 6 years old attending an asthma referral center. This is a retrospective population-based cohort study performed in children with asthma aged 0-5 years, attending at "Io e l'Asma center", Brescia, Italy between September 2007 and December 2014. The incidence rates (IRs) of hospitalization, emergency room visits, use of outpatient services and drug usage for dyspnea, wheezing, or respiratory symptoms were evaluated for time periods prior to and after DTEP intervention. A total of 741 patients, aged 0-5 years completed the DTEP, including 391 and 350 children aged 0-2 and 3-5 years, respectively. The percentage of children aged 0-2 and 3-5 years showing improved control of wheezing symptoms during the 1st to 3rd visit interval as a result of the DTEP intervention increased from 39.5 to 60.9% and from 25.5 to 75.5%, respectively. During these periods, the IRs showed a significant decrease for all outcomes, from-8.6% to - 80.4%. Although specific IRs for drug prescriptions declined, particularly for LABA plus corticosteroids, antibiotics, and systemic corticosteroids, they increased for SABA, inhaled corticosteroid and leukotriene receptor antagonist usage. The results suggest that a real-world assessment of the integrated DTEP program for preschool children provides evidence for improved wheezing control and reduction of adverse therapeutic related outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Preschool children with clinically-diagnosed asthma have a higher rate of emergency department visits and consume more resources for management than older children. However, no clinical trials have yet been performed measuring the impact of a combined diagnostic, therapeutic and educational pathway regimen for evaluation of wheezing control in children aged less than 6 years. The purpose of the present study was to assess the impact of a pediatric program developed in Italy, the Diagnostic Therapeutic Educational Pathway (DTEP), for asthma management in children less than 6 years old attending an asthma referral center.
METHODS METHODS
This is a retrospective population-based cohort study performed in children with asthma aged 0-5 years, attending at "Io e l'Asma center", Brescia, Italy between September 2007 and December 2014. The incidence rates (IRs) of hospitalization, emergency room visits, use of outpatient services and drug usage for dyspnea, wheezing, or respiratory symptoms were evaluated for time periods prior to and after DTEP intervention.
RESULTS RESULTS
A total of 741 patients, aged 0-5 years completed the DTEP, including 391 and 350 children aged 0-2 and 3-5 years, respectively. The percentage of children aged 0-2 and 3-5 years showing improved control of wheezing symptoms during the 1st to 3rd visit interval as a result of the DTEP intervention increased from 39.5 to 60.9% and from 25.5 to 75.5%, respectively. During these periods, the IRs showed a significant decrease for all outcomes, from-8.6% to - 80.4%. Although specific IRs for drug prescriptions declined, particularly for LABA plus corticosteroids, antibiotics, and systemic corticosteroids, they increased for SABA, inhaled corticosteroid and leukotriene receptor antagonist usage.
CONCLUSIONS CONCLUSIONS
The results suggest that a real-world assessment of the integrated DTEP program for preschool children provides evidence for improved wheezing control and reduction of adverse therapeutic related outcomes.

Identifiants

pubmed: 33691759
doi: 10.1186/s13052-021-00992-y
pii: 10.1186/s13052-021-00992-y
pmc: PMC7944593
doi:

Substances chimiques

Anti-Asthmatic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60

Références

Eur Respir J. 2014 Apr;43(4):1172-7
pubmed: 24525447
Pediatr Allergy Immunol. 2018 Mar;29(2):180-185
pubmed: 29168239
J Allergy Clin Immunol. 2016 Dec;138(6):1608-1618.e12
pubmed: 27777180
Allergy Asthma Proc. 2016 Jul;37(4):70-6
pubmed: 27401311
BMC Med. 2017 Mar 17;15(1):64
pubmed: 28302126
J Allergy Clin Immunol. 2015 Oct;136(4):829-36; quiz 837
pubmed: 26449797
Prim Care Respir J. 2007 Dec;16(6):357-62
pubmed: 18038103
J Asthma Allergy. 2010 Dec 10;3:187-97
pubmed: 21437053
Eur Respir J. 2008 Oct;32(4):1096-110
pubmed: 18827155
Chest. 2006 Apr;129(4):909-17
pubmed: 16608938
Can Respir J. 2015 May-Jun;22(3):135-43
pubmed: 25893310
Lancet. 2003 Mar 29;361(9363):1071-6
pubmed: 12672309
Ital J Pediatr. 2017 Jun 24;43(1):58
pubmed: 28646883
Front Pediatr. 2020 Mar 11;8:39
pubmed: 32219081
Lancet. 2014 May 3;383(9928):1593-604
pubmed: 24792856
Chest. 2004 May;125(5):1680-4
pubmed: 15136376
JAMA. 2012 Mar 28;307(12):1284-91
pubmed: 22453569

Auteurs

Sebastiano Guarnaccia (S)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. guarnaccia.s@gmail.com.

Cristina Quecchia (C)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Andrea Festa (A)

Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, University of Brescia, Brescia, Italy.

Michele Magoni (M)

Brescia Health Protection Agency, Brescia, Italy.

Giuseppe Zenoni (G)

Post-Graduate School of Public Health, University of Brescia, Brescia, Italy.

Emanuele D'Agata (E)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Valentina Brivio (V)

Post-Graduate School of Public Health, University of Brescia, Brescia, Italy.

Elena Zanardini (E)

Post-Graduate School of Public Health, University of Brescia, Brescia, Italy.

Carmelo Scarcella (C)

ASST Garda, Desenzano, Italy.

Valeria Gretter (V)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Susanna Facchetti (S)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Cinzia Gasparotti (C)

Brescia Health Protection Agency, Brescia, Italy.

Ada Pluda (A)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Malica Frassine (M)

Centro "Io e l'Asma", Ospedale dei Bambini, ASST Spedali Civili, Brescia, Italy.

Rosa Maria Limina (RM)

ASST Lariana, Como, Italy.

Raffaele Spiazzi (R)

I.R.C.C.S. Giannina Gaslini, Genoa, Italy.

Raffaele Badolato (R)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Bruce Bender (B)

Department of Pediatrics, Center for Health Promotion National Jewish Health, Colorado, Denver, USA.

Francesco Donato (F)

Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH